Customer Appreciation Sale.
15% off with promo code "APPRECIATION2023" on check out or purchase order
- Sakamoto K, .et al. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response, Leukemia, 2018, May 23 PMID: 29795241
- W. Joost Lesterhuis, .et al. Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations, Sci Rep, 2015, 5: 12298 PMID: 26193793
Biological Activity
VX-680 is a potent and selective small-molecule inhibitor of the Aurora kinases.
Targets
Aurora A (Cell-free assay) | Aurora C (Cell-free assay) | Aurora B (Cell-free assay) | FLT3 (Cell-free assay) | Bcr-Abl (Cell-free assay) |
0.6 nM(Ki app) | 4.6 nM(Ki app) | 18 nM(Ki app) | 30 nM(Ki) | 30 nM(Ki) |
In vitro (25°C) | DMSO | 90 mg/mL (193.71 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 5% DMSO+30% PEG 300+2% Tween 80+ddH2O | 14 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.52 mL | 107.62 mL | 215.24 mL |
0.5 mM | 4.3 mL | 21.52 mL | 43.05 mL |
1 mM | 2.15 mL | 10.76 mL | 21.52 mL |
5 mM | 0.43 mL | 2.15 mL | 4.3 mL |
*The above data is based on the productmolecular weight 464.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A10981 |
---|---|
Actions | Inhibitor |
CAS No. | 639089-54-6 |
Formula | C23H28N8OS |
M. Wt | 464.6 |
Purity | >98% |
SMILES | CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Datasheet
Product Tags
Product Questions
Product Questions
No Questions
You may also be interested in the following product(s)
AZD1480
AZD1480 is a novel potent small JAK2 inhibitor with an IC50 of 0.26 nM.
Filgotinib
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
TG101209
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ mye…
INCB018424 (Ruxolitinib)
INCB018424 is a potent and selective inhibitor of Janus-associated kinase (JAK) 1 and 2, with IC50 to be 2.7, 4.5 and 332 nM for JAK1, JAK2 …
WHI-P 154
WHI-P 154 is a JAK3 inhibitor with IC50 = 1.8uM. WHI-P 154 also Inhibits STAT1 activation, iNOS expression and NO production in macrophages…
TG-101348 (Fedratinib, SAR302503)
TG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic acti…
FLLL32
FLLL32 is a potent JAK2/STAT3 inhibitor with IC50 of
PP2
PP2 is a selective inhibitor of Src-family tyrosine kinases. Inhibits p56lck and p59fynT (IC50 values are 4 and 5 nM respectively). Displays…
Keywords:buy VX-680 (MK-0457, Tozasertib) | VX-680 (MK-0457, Tozasertib) Supplier | purchase | cost | manufacturer | order | distributor | buy 639089-54-6| 639089-54-6 Supplier | purchase 639089-54-6 | 639089-54-6 cost | 639089-54-6 manufacturer | order 639089-54-6 | 639089-54-6 distributor